Search

everythinglearnresearchcommunity

for

Search:↓

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Finasteride affects young male rats' brain function and behavior negatively.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Monkeys with hair loss during pregnancy showed higher stress hormone levels and invested differently in their offspring.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Skin problems can indicate different diseases inside the body.

Women with irregular periods have a higher risk of heart disease.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Thyroid function may influence hair loss after COVID-19.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.